Belatacept as maintenance immunosuppression for postrenal transplant de novo drug-induced thrombotic microangiopathy.

MLA

Ashman, N., et al. “Belatacept as Maintenance Immunosuppression for Postrenal Transplant de Novo Drug-Induced Thrombotic Microangiopathy.” American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons, vol. 9, no. 2, Feb. 2009, pp. 424–27. EBSCOhost, https://doi.org/10.1111/j.1600-6143.2008.02482.x.

APA

Ashman, N., Chapagain, A., Dobbie, H., Raftery, M. J., Sheaff, M. T., & Yaqoob, M. M. (2009). Belatacept as maintenance immunosuppression for postrenal transplant de novo drug-induced thrombotic microangiopathy. American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons, 9(2), 424–427. https://doi.org/10.1111/j.1600-6143.2008.02482.x

Chicago

Ashman, N, A Chapagain, H Dobbie, M J Raftery, M T Sheaff, and M M Yaqoob. 2009. “Belatacept as Maintenance Immunosuppression for Postrenal Transplant de Novo Drug-Induced Thrombotic Microangiopathy.” American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons 9 (2): 424–27. doi:10.1111/j.1600-6143.2008.02482.x.